No abstract available
MeSH terms
-
Administration, Oral
-
CCR5 Receptor Antagonists
-
Cyclohexanes / administration & dosage
-
Cyclohexanes / adverse effects
-
Cyclohexanes / economics
-
Cyclohexanes / therapeutic use*
-
Drug Administration Schedule
-
Drug Costs
-
Drug Interactions
-
Drug Resistance, Viral
-
HIV Fusion Inhibitors / administration & dosage
-
HIV Fusion Inhibitors / adverse effects
-
HIV Fusion Inhibitors / economics
-
HIV Fusion Inhibitors / therapeutic use*
-
HIV Infections / drug therapy*
-
HIV Infections / virology
-
HIV Integrase Inhibitors / administration & dosage
-
HIV Integrase Inhibitors / adverse effects
-
HIV Integrase Inhibitors / economics
-
HIV Integrase Inhibitors / therapeutic use*
-
HIV-1 / drug effects*
-
HIV-1 / enzymology
-
Humans
-
Maraviroc
-
Organic Chemicals / administration & dosage
-
Organic Chemicals / adverse effects
-
Organic Chemicals / economics
-
Organic Chemicals / therapeutic use*
-
Pyrrolidinones
-
Raltegravir Potassium
-
Treatment Outcome
-
Triazoles / administration & dosage
-
Triazoles / adverse effects
-
Triazoles / economics
-
Triazoles / therapeutic use*
Substances
-
CCR5 Receptor Antagonists
-
Cyclohexanes
-
HIV Fusion Inhibitors
-
HIV Integrase Inhibitors
-
Organic Chemicals
-
Pyrrolidinones
-
Triazoles
-
Raltegravir Potassium
-
Maraviroc